Publicaciones en colaboración con investigadoras/es de Fondazione IRCCS Istituto Nazionale dei Tumori (10)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

  2. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study

    The Lancet Oncology, Vol. 25, Núm. 6, pp. 731-743

2023

  1. Cancer data quality and harmonization in Europe: the experience of the BENCHISTA Project – international benchmarking of childhood cancer survival by stage

    Frontiers in Oncology, Vol. 13

  2. Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment

    Cancers, Vol. 15, Núm. 24

  3. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 593-606

  4. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

2021

  1. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

2020

  1. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

    Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602

2018

  1. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 201-211

2017

  1. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

    European Journal of Cancer, Vol. 84, pp. 335-353